Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis
Clinical trial NCT04018027 · COMPLETED
Trial details
- NCT number
- NCT04018027
- Sponsor
- Cara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-29
- Primary completion
- 2021-04-01
- Enrollment
- 401
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.